Immunotherapy drug clinical trial results: half of tumors shrink or disappear
The researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.
Mapping gene expression and epigenetic changes that cause "undead" cancer cells to trigger cancer-promoting inflammation
Visit rockefeller.edu → On Hacker News Jul 2019 – Sep 2025
Science & Space 4Society, Policy & Culture 3History & Retro Computing 1
The researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.
Results of automated DNA sequencing, displayed on the screen of a tablet computer. (Turtle Rock Scientific/Science Photo Library)
Mitchell J. Feigenbaum , a mathematical physicist whose groundbreaking work on deterministic chaos influenced fields ranging from cardiology to cartography, died in New York City on June 30 at the age of 74. Feigenbaum was the Toyota Professor and director of the Center for Studies in Physics and Biology at…
To find bioactive molecules with the potential to become new drugs less prone to antibiotic resistance, the researchers sequenced bacterial DNA extracted from soils from Rockefeller’s field center in upstate New York. (Brady lab)